| Autor: |
Kneitz C; Rheumatologische Schwerpunktpraxis Schwerin, Beethovenstr. 3, 19053, Schwerin, Deutschland. christian.kneitz@rheuma-schwerin.de., Krüger K; Rheumatologisches Praxiszentrum, München, Deutschland. |
| Jazyk: |
němčina |
| Zdroj: |
Zeitschrift fur Rheumatologie [Z Rheumatol] 2021 Mar; Vol. 80 (2), pp. 149-157. |
| DOI: |
10.1007/s00393-020-00938-5 |
| Abstrakt: |
Infections affect morbidity and mortality of patients suffering from rheumatic diseases in an important way. Risk of infection is influenced generally by age and existing comorbidities as well as especially by activity of the rheumatic disease and immunosuppressive treatment. Correspondingly best possible reduction of disease activity and elimination or at least successful treatment of comorbidities are able to reduce infection risk. Patients at high risk of infection should be identified and be monitored in an intensified way. Furthermore risk is influenced by antirheumatic treatment, e.g. enhanced by long-term glucocorticoid treatment, reduced by optimisied use of disease-modifying antirheumatic drugs leading to best possible disease control. Finally protective antibiotic or antiviral treatment (e.g. in case of latent tuberculosis or hepatitis) as well as optimised vaccination status are able to reduce risk of infection further. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink